
Madhu P. Menon, MD, PhD, FCAP
Medical Director: Hematopathology
Associate Professor, University of Utah School of Medicine
Specialties
- Hematopathology and hematology (benign and malignant)
- Molecular hematopathology
- Lymphomas (Hodgkin and non-Hodgkin)
- Leukemias
Education
- Medical Degree—Baroda Medical College, Maharaja Sayajirao University
- Doctorate Degree—Molecular Medicine, Huck Institute of Life Sciences, Pennsylvania State University
- Residency—Anatomic and Clinical Pathology, University of Massachusetts Medical School
- Fellowship—Hematopathology, National Institutes of Health/National Cancer Institute
- Fellowship—Hematopathology, Johns Hopkins University Hospital
- Fellowship—Hematopathology, George Washington University Hospital
- Fellowship—Postdoctoral Fellow, Maine Medical Center Research Institute
Certification/Affiliations
- American Board of Pathology, Hematopathology
- American Board of Pathology, Anatomic Pathology
- American Board of Pathology, Clinical Pathology
- LEAN Silver Certification, LEAN Training for Healthcare Leaders
Research Interests
- Diagnostic and prognostic markers in lymphomas
- Molecular characterization of lymphomas
- Biomarkers for early detection of progression and transformation of low-grade lymphomas
Awards
- 2018–2019 Teacher of the Year, Henry Ford Pathology Residency Program
- 2015–2016 Teacher of the Year, Henry Ford Pathology Residency Program
- 2014 Fellow, American Society for Clinical Pathology (FASCP)
- Dec 2011 Fellow, College of American Pathologists (FCAP)
- 2010 Stowell–Orbison Award Nominee, United States and Canadian Academy of Pathology (USCAP)
- 2010 Association of Indian Pathologists in North America (AIPNA) USCAP Poster Award
- 2009–2010 College of American Pathologists (CAP) Advanced Hematopathology Training Award
- Aug 2001–Aug 2003 J. Huck Institute of Life Sciences Predoctoral Fellowship Award in Molecular Medicine: Integrative Biosciences Program, Pennsylvania State University
Recent Publications
- Anderson J, et al. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase. Int J Lab Hematol, 2021. (Online ahead of print)
- Friedman B, et al. An elderly male with a chronic rash of the right foot. Ind Jour of Derm. 2020;65(3):222–24.
- Van Slambrouck C, et al. Diagnostic utility of STAT6(YE361) expression in classical Hodgkin lymphoma and related entities. Mod Pathol. 2020;33(5):834–45.
- Vaddepally RK, eta l. A rare case of follicular lymphoma transformed to a high-grade B-cell lymphoma in orbit. Clin Case Rep. 2019;7(5):1053–56.
- Karner KH, et al. Post-transplant CD4+ non-cytotoxic gamma delta T cell lymphoma with lymph node involvement. J Hematopathol. 2018;11:107.
- Kezlarian B, et al. GATA3 immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities. Appl Immunohistochem Mol Morphol. 2019 Mar;27(3):180–84.
- Datta L, et al. Plasmacytoid lymphocytes: a clue to dengue diagnosis. Blood. 2017;129(15):2202.
- Alikhan M, et al. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3-/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol. 2016;(10):1173–82.